Follow The Filings

VRDN Viridian Therapeutics

Viridian Therapeutics earnings company data as of 6:59 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by VRDN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VRDN insider trades
  • $30M bought by 1 insider
  • $419K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Jennifer Tousignant Chief Legal Officer
    Sale
    $348K 14,212 shares at $24.50 100% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  2. Fairmount Funds Management LLC Director, +2 joint filers
    Buy
    $20M 1,176,470 shares at $17.00 +30% to stake
    Traded May 11 Filed May 13
    ↗
  3. Jennifer Tousignant Chief Legal Officer
    Sale
    $71K 2,272 shares at $31.16 100% of stake
    Traded Dec 31, 2025 Filed Jan 2
    ↗
  4. Fairmount Funds Management LLC Director, +2 joint filers
    Buy
    $10M 454,545 shares at $22.00 +13% to stake
    Traded Oct 23, 2025 Filed Oct 27, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 option exercises and 4 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
8-K 1.02 Filing Doc
8-K 1.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
424B5 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.